Bectumomab
| Monoclonal antibody | |
|---|---|
| Type | Fab' fragment |
| Source | Mouse |
| Target | CD22 |
| Clinical data | |
| Trade names | LymphoScan |
| Identifiers | |
158318-63-9  | |
| None | |
| Chemical data | |
| (what is this?) (verify) | |
Bectumomab (marketed under the trade name LymphoScan) is a mouse monoclonal antibody labelled with the radioactive isotope technetium-99m. It is used to detect non-Hodgkin's lymphoma.[1][2]
References
- ↑ WHO Drug Information
- ↑ Lamonica, D.; Czuczman, M.; Nabi, H.; Klippenstein, D.; Grossman, Z. (2002). "Radioimmunoscintigraphy (RIS) with Bectumomab (Tc99m labeled IMMU-LL2, Lymphoscan) in the assessment of recurrent non-Hodgkin's lymphoma (NHL)". Cancer biotherapy & radiopharmaceuticals 17 (6): 689–697. doi:10.1089/108497802320970307. ISSN 1084-9785. PMID 12537673.